Filing metadata

Accession number
0000902664-23-003751
Form type
Form 4
Filer
Ambrx Biopharma Cayman, Inc.
CIK
CIK 1836056
Filed
Jun 28, 2023
Reporting period
Jun 27, 2023
Description
Insider transaction

Explore SEC Filings Hub